PERCEPTIVE ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM)

Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Security
Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share
Symbol
CTNM
Shares outstanding
21,858,938 shares
Disclosed Ownership
699,486 shares
Ownership
3.2%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:26:41 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"PERCEPTIVE ADVISORS LLC disclosed 3.2% ownership in Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM) on 30 Jun 2025."

Quick Takeaways

  • PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM).
  • Disclosed ownership: 3.2%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Aug 2025, 16:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 3.2% 699,486 0 699,486 /s/ Joseph Edelman Joseph Edelman, Managing Member
Joseph Edelman 3.2% 699,486 0 699,486 /s/ Joseph Edelman Joseph Edelman
Perceptive Life Sciences Master Fund, Ltd. 3.2% 699,486 0 699,486 /s/ Joseph Edelman Joseph Edelman, Managing Member

Sponsored